Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Amphastar Pharmaceuticals, Inc. (AMPH)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $719.9M | $732.0M | $644.4M | $499.0M | $437.8M | $349.8M | $322.4M | $294.7M | $240.2M | $255.2M | $251.5M | $210.5M | $229.7M | $204.3M |
| Gross profit | $356.1M | $373.9M | $351.1M | $248.9M | $199.7M | $143.3M | $131.9M | $107.0M | $90.5M | $104.2M | $77.3M | $51.3M | $87.0M | $90.3M |
| Research & development | $85.8M | $73.9M | $73.7M | $74.8M | $60.9M | $67.2M | $68.9M | $57.6M | $43.5M | $41.5M | $37.3M | $28.9M | $33.0M | $31.2M |
| Operating expenses | $215.7M | $168.4M | $154.1M | $141.4M | $129.9M | $132.4M | $132.0M | $115.6M | $91.8M | $88.8M | $84.2M | $69.2M | $69.5M | $64.9M |
| Operating income | $140.4M | $205.4M | $197.0M | $107.5M | $69.9M | $11.0M | −$39,000 | −$8.6M | −$1.3M | $15.4M | −$6.9M | −$18.0M | $17.5M | $25.4M |
| EBITDAderived | $197.1M | $258.4M | $222.7M | $120.1M | $80.1M | $20.0M | $7.0M | −$2.6M | $5.2M | $30.1M | $6.4M | −$3.5M | $30.6M | $36.9M |
| Net income | $98.1M | $159.5M | $137.5M | $91.4M | $62.1M | $1.4M | $48.9M | −$5.7M | $3.6M | $9.8M | −$2.8M | −$10.7M | $11.9M | $18.1M |
| Basic EPSper diluted share | $2.10 | $3.29 | $2.85 | $1.88 | $1.30 | $0.03 | $1.04 | -$0.12 | $0.08 | $0.22 | -$0.06 | -$0.25 | $0.31 | $0.47 |
| Diluted EPSper diluted share | $2.03 | $3.06 | $2.60 | $1.74 | $1.25 | $0.03 | $0.98 | -$0.12 | $0.08 | $0.21 | -$0.06 | -$0.25 | $0.31 | $0.46 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 17, 2025Form 4 | Zhou RongSENIOR EVP, PRODUCTION CENTER | SellCommon Stock | 9.8K | $26.20 | $256.4K | 138.0K |
| Dec 12, 2025Form 4 | Petersen Floyd F.Director | SellCommon Stock | 2.4K | $25.92 | $62.9K | 71.4K |
| Dec 11, 2025Form 4 | Petersen Floyd F.Director | SellCommon Stock | 1.7K | $25.69 | $44.6K | 73.8K |
| Nov 25, 2025Form 4 | PRINS RICHARD KDirector | SellCommon Stock | 4.2K | $27.10 | $113.3K | 35.2K |
| Nov 13, 2025Form 4 | Petersen Floyd F.Director | SellCommon Stock | 16.7K | $26.49 | $441.8K | 75.5K |